Autzen Virtanen, A. and Myslinska, M. and Healy, A.M. and Power, E. and Madi, A. and Siven, M., The challenge of downstream processing of spray dried amorphous solid dispersions into minitablets designed for the paediatric population - A sustainable product development approach, European Journal of Pharmaceutical Sciences, 196, (106752), 2024,
Notes: [cited By 1],
Journal Article,
PUBLISHED
DOI
|
Andrews, G.P. and Healy, A.M. and Topp, E.M., Introducing the Molecular Pharmaceutics Special Issue on "Advances in Small and Large Molecule Pharmaceutics Research across Ireland", Molecular Pharmaceutics, 21, (8), 2024, p3693-3694 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Piatek, M. and Grassiri, B. and O'Ferrall, L.M. and Piras, A.M. and Batoni, G. and Esin, S. and O'Connor, C. and Griffith, D. and Healy, A.M. and Kavanagh, K., Quantitative proteomic analysis reveals Ga(III) polypyridyl catecholate complexes disrupt Aspergillus fumigatus mitochondrial function, Journal of Biological Inorganic Chemistry, 29, 2024, p707 - 717,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Grassiri B, Esin S, Piatek ME, More O'Ferrall L, Sake JA, Griffith DM, Kavanagh K, Ehrhardt C, Maria Piras A, Batoni G, Marie Healy A, The activity of a Ga(III) catecholate complex against Aspergillus fumigatus in conditions mimicking cystic fibrosis lung and inhaled formulations for its pulmonary administration., International Journal of Pharmaceutics, 667, (A), 2024, p124871 ,
Journal Article,
PUBLISHED
DOI
|
Simon A., Velloso-Junior S.O., Mesquita R.D., Fontao A.P.G.A., Costa T.E.M.M., Honorio T.S., Guimaraes T.F., Sousa E.G.R., Vicosa A.L., Sampaio A.L.F., do Carmo F.A., Healy A.M., Cabral L.M., Castro R.R., Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment, International Journal of Pharmaceutics, 666, 2024, p124740 ,
Journal Article,
PUBLISHED
DOI
|
Taseva AR, Persoons T, Healy AM, D'Arcy DM., Application of shadowgraph imaging (SGI) particle characterisation data to interpret the impact of varying test conditions on powder dissolution and to develop an automated agglomeration identification method (AIM) in the USP flow-through apparatus., International journal of pharmaceutics, 666, 2024, p124778 ,
Journal Article,
PUBLISHED
DOI
|
Tsolaki E., Healy A.M., Ferguson S., Development of polymer-encapsulated microparticles of a lipophilic API-IL and its lipid based formulations for enhanced solubilisation, International Journal of Pharmaceutics, 667, 2024, p124878 ,
Journal Article,
PUBLISHED
DOI
|
Fernández-García R, Walsh D, O'Connell P, Slowing K, Raposo R, Paloma Ballesteros M, Jiménez-Cebrián A, Chamorro-Sancho MJ, Bolás-Fernández F, Healy AM, Serrano DR., Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses., European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 183, 2023, p74-91 ,
Journal Article,
PUBLISHED
DOI
|
Stocker MW, Tsolaki E, Harding MJ, Healy AM, Ferguson S., Combining Isolation-Free and Co-processing Manufacturing Approaches to Access Room Temperature Ionic Liquid Forms of APIs., Journal of pharmaceutical sciences, 2023, pS0022-3549(23)00052-7 ,
Journal Article,
PUBLISHED
DOI
|
Myslinska M, Stocker MW, Ferguson S, Healy AM., A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin., Journal of pharmaceutical sciences, 2023, pS0022-3549(23)00064-3 ,
Journal Article,
PUBLISHED
DOI
|
|